• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多学科方法治疗多瓣膜感染性心内膜炎伴多器官受累

A Multidisciplinary Approach to Triple-Valve Infective Endocarditis With Multi-Organ Involvement.

机构信息

Medical College of Georgia at Augusta University, Augusta, GA, USA.

Division of Infectious Diseases, Department of Medicine, Medical College of Georgia, WellStar MCG Health, Augusta, GA, USA.

出版信息

J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241265917. doi: 10.1177/23247096241265917.

DOI:10.1177/23247096241265917
PMID:39107989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11304477/
Abstract

Multivalvular endocarditis is a rare and potentially fatal complication that can occur in people who inject drugs. Currently, there are few cases that have been studied or reported in literature. A complication of this manifestation that worsens prognosis and treatment is the distribution of septic emboli throughout the body which highlights the dissemination of the infection. There are no specific guidelines on the treatment of multivalvular endocarditis, but its complexity can present challenges in administering medical and surgical treatment. In this case of a 37-year-old man with infective endocarditis of 3 valves, a comprehensive work-up found septic emboli in the lungs, kidneys, ribs, spine, and brain with ophthalmologic involvement that resulted in visual impairment. This case highlights important complications that can occur with septic emboli and management of these issues using a multidisciplinary approach including the treatment of substance use disorder.

摘要

多瓣膜心内膜炎是一种罕见且可能致命的并发症,可发生于吸毒人群。目前,文献中研究或报道的病例很少。这种表现的一个使预后和治疗恶化的并发症是全身感染性栓子的分布,这突出了感染的传播。对于多瓣膜心内膜炎的治疗尚无具体指南,但由于其复杂性,在实施药物和手术治疗时可能会遇到挑战。本例为一名 37 岁男性,患有三尖瓣感染性心内膜炎,全面检查发现肺部、肾脏、肋骨、脊柱和大脑中有感染性栓子,且眼部受累导致视力障碍。该病例强调了感染性栓子可能发生的重要并发症,以及采用多学科方法(包括治疗物质使用障碍)来管理这些问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/0d18eb90acf4/10.1177_23247096241265917-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/99089d38a80f/10.1177_23247096241265917-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/b27b65e1945d/10.1177_23247096241265917-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/b3b13e29cf03/10.1177_23247096241265917-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/31f628e6bc14/10.1177_23247096241265917-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/0d18eb90acf4/10.1177_23247096241265917-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/99089d38a80f/10.1177_23247096241265917-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/b27b65e1945d/10.1177_23247096241265917-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/b3b13e29cf03/10.1177_23247096241265917-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/31f628e6bc14/10.1177_23247096241265917-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81a5/11304477/0d18eb90acf4/10.1177_23247096241265917-fig5.jpg

相似文献

1
A Multidisciplinary Approach to Triple-Valve Infective Endocarditis With Multi-Organ Involvement.多学科方法治疗多瓣膜感染性心内膜炎伴多器官受累
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241265917. doi: 10.1177/23247096241265917.
2
Antibiotic prophylaxis for preventing bacterial endocarditis following dental procedures.牙科操作后预防细菌性心内膜炎的抗生素预防。
Cochrane Database Syst Rev. 2022 May 10;5(5):CD003813. doi: 10.1002/14651858.CD003813.pub5.
3
Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers.金黄色葡萄球菌携带者鼻腔去污预防手术部位感染
Cochrane Database Syst Rev. 2017 May 18;5(5):CD012462. doi: 10.1002/14651858.CD012462.pub2.
4
Host-Bacterium Interaction Mechanisms in Endocarditis: A Systematic Review.心内膜炎中宿主-细菌相互作用机制:系统评价。
Int J Mol Sci. 2023 Jul 4;24(13):11068. doi: 10.3390/ijms241311068.
5
A comparison of different antibiotic regimens for the treatment of infective endocarditis.不同抗生素治疗方案用于感染性心内膜炎治疗的比较
Cochrane Database Syst Rev. 2016 Apr 19;4:CD009880. doi: 10.1002/14651858.CD009880.pub2.
6
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.根除囊性纤维化患者体内耐甲氧西林金黄色葡萄球菌(MRSA)的干预措施。
Cochrane Database Syst Rev. 2018 Jul 21;7(7):CD009650. doi: 10.1002/14651858.CD009650.pub4.
7
Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.达托霉素用于治疗心内膜炎和/或菌血症:对实验和临床证据的系统评价
J Antimicrob Chemother. 2007 Jul;60(1):7-19. doi: 10.1093/jac/dkm137. Epub 2007 Jun 4.
8
Antibiotics for the prophylaxis of bacterial endocarditis in dentistry.用于牙科预防细菌性心内膜炎的抗生素
Cochrane Database Syst Rev. 2008 Oct 8(4):CD003813. doi: 10.1002/14651858.CD003813.pub3.
9
Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.囊性纤维化患者慢性甲氧西林敏感金黄色葡萄球菌肺部感染的治疗
Cochrane Database Syst Rev. 2018 Jul 27;7(7):CD011581. doi: 10.1002/14651858.CD011581.pub3.
10
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.

本文引用的文献

1
Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews.物质使用障碍治疗的障碍与促进因素:系统评价综述
Subst Abuse. 2022 Aug 29;16:11782218221118462. doi: 10.1177/11782218221118462. eCollection 2022.
2
Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association.《美国心脏协会关于注射吸毒者感染性心内膜炎管理的科学声明》
Circulation. 2022 Oct 4;146(14):e187-e201. doi: 10.1161/CIR.0000000000001090. Epub 2022 Aug 31.
3
Multivalvular Endocarditis: A Rare Condition with Poor Prognosis.
多瓣膜心内膜炎:一种预后不良的罕见病症。
J Clin Med. 2022 Aug 13;11(16):4736. doi: 10.3390/jcm11164736.
4
The Global, Regional, and National Burden and Trends of Infective Endocarditis From 1990 to 2019: Results From the Global Burden of Disease Study 2019.1990年至2019年感染性心内膜炎的全球、地区和国家负担及趋势:全球疾病负担研究2019结果
Front Med (Lausanne). 2022 Mar 9;9:774224. doi: 10.3389/fmed.2022.774224. eCollection 2022.
5
More Than Meets the Eye: Infective Endocarditis Presenting as Endogenous Endophthalmitis.表象之下:以眼内炎为表现的感染性心内膜炎
Cureus. 2021 Apr 28;13(4):e14745. doi: 10.7759/cureus.14745.
6
Addiction Management in Hospitalized Patients With Intravenous Drug Use-Associated Infective Endocarditis.静脉吸毒相关性感染性心内膜炎住院患者的成瘾管理。
Psychosomatics. 2020 Nov-Dec;61(6):678-687. doi: 10.1016/j.psym.2020.06.019. Epub 2020 Jul 2.
7
Right-Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment.2020 年右心感染性心内膜炎:诊断和治疗中的挑战与更新。
J Am Heart Assoc. 2020 Aug 4;9(15):e017293. doi: 10.1161/JAHA.120.017293. Epub 2020 Jul 23.
8
Current AATS guidelines on surgical treatment of infective endocarditis.美国胸外科医师协会(AATS)目前关于感染性心内膜炎外科治疗的指南。
Ann Cardiothorac Surg. 2019 Nov;8(6):630-644. doi: 10.21037/acs.2019.10.05.
9
Impact of β-Lactam and Daptomycin Combination Therapy on Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Bacteremia: A Propensity Score-matched Analysis.β-内酰胺与达托霉素联合治疗对甲氧西林敏感金黄色葡萄球菌菌血症临床结局的影响:一项倾向评分匹配分析
Clin Infect Dis. 2019 Oct 15;69(9):1480-1488. doi: 10.1093/cid/ciz018.
10
Incidence and Risk Factors of Ocular Infection Caused by Staphylococcus aureus Bacteremia.金黄色葡萄球菌菌血症所致眼部感染的发病率及危险因素
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2012-7. doi: 10.1128/AAC.02651-15. Print 2016 Apr.